Acute Effect of Nitrate From Natural Dietary Sources on Arterial Stiffness and Blood Pressures in Healthy Individuals
NCT ID: NCT01604993
Last Updated: 2014-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
31 participants
INTERVENTIONAL
2011-10-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection
NCT02694848
Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients
NCT04269863
Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting
NCT00966485
Aspirin for Prevention of Stroke After Endovascular Aortic Arch Repair: a Multicenter, Double-Blind, Randomized Controlled Trial
NCT07205250
Heart Outcomes Prevention Evaluation-3
NCT00468923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High nitrate dietary source
556 grams of high nitrate spinach soup that is orally consumed as a single dose for 7 days.
Spinach soup
556 g of high Nitrate spinach soup that is orally consumed as a single dose for 7 days
No Nitrate dietary source
556g low nitrate asparagus soup; orally consumed as a single does for 7 days.
Asparagus soup
556 grams of low nitrate asparagus soup that is orally consumed for a period of 7 days as a single does
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spinach soup
556 g of high Nitrate spinach soup that is orally consumed as a single dose for 7 days
Asparagus soup
556 grams of low nitrate asparagus soup that is orally consumed for a period of 7 days as a single does
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must consider themselves to be in good overall health and be free of any conditions or illnesses Women must be post-menopausal or not pregnant.
* Body mass index (BMI) must be \<30kg/m\^2.
* Normotensive, as defined by brachial SBP \<140mmHg and DBP \<90mmHg
* Subjects must also be willing to stop using mouthwash for the duration of their participation in the study.
Exclusion Criteria
* BMI \>30kg/m\^2
* Hypertensive as defined by brachial SBP \>140mmHg and/or DBP \>90mmHg
* Allergy or sensitivity to the study product, reference therapy or nitrates
* Having any gastrointestinal complication or condition
* Chronic use of medications such as prescription NSAIDs, antacids, blood-thinners, hypertensive medications, medications affecting NO synthesis such as Viagra, and use of antibiotics within one month of the study start
* Individuals who are involved in another clinical trial.
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unity Health Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vladimir Vuksan, PhD
Role: PRINCIPAL_INVESTIGATOR
Risk Factor Modification Centre - St. Michael's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Risk Factor Modification Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11216
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.